Gerald Chan
CIK 1636579 · last filed 2026-05-14
Gerald Chan is a corporate insider who has filed 13 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for APLS, was dated May 14, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
13
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Director | 0 | $41.03 | $0 | $0 | 9 | 2026-05-14 |
| CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Director | — | — | — | $0 | 4 | 2018-06-08 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −49,854 | $0 | EDGAR |
| 2026-01-05 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +7,961 | $0 | EDGAR |
| 2025-01-03 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +6,267 | $0 | EDGAR |
| 2024-01-02 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +3,341 | $0 | EDGAR |
| 2023-01-04 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +3,867 | $0 | EDGAR |
| 2022-01-04 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +4,230 | $0 | EDGAR |
| 2021-01-04 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-03 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-08 | CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Grant (A) | — | $0 | EDGAR |